Sucampo Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Sucampo Pharma (SCMP) Misses Q1 EPS by 17c, Reiterates FY Guidance
May 3, 2017 6:37 AM EDTSucampo Pharma (NASDAQ: SCMP) reported Q1 EPS of $0.10, $0.17 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $56.3 million versus the consensus estimate of $54.14 million.
Sucampo today reiterated its guidance for the full year ending December 31, 2017. Sucampo expects total revenue of... More



